Evidence map›Paper›PMID 37958717›Full record

ArticleInternational journal of molecular sciences2023

Newly Synthesized CoFe

Slaviţa Rotunjanu, Roxana Racoviceanu, Alexandra Mioc, Andreea Milan, Roxana Negrea-Ghiulai, Marius Mioc, Narcisa Laura Marangoci, Codruţa Şoica

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Newly Synthesized CoFeNanomaterials (Basel, Switzerland) · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Slaviţa RotunjanuDepartment of Pharmacology-Pharmacotherapy, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Roxana RacoviceanuDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timişoara, Romania.ORCID 0000-0002-3378-0774
Alexandra MiocDepartment of Pharmacology-Pharmacotherapy, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Andreea MilanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timişoara, Romania.ORCID 0000-0002-6588-3241
Roxana Negrea-GhiulaiDepartment of Pharmacology-Pharmacotherapy, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Marius MiocDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timişoara, Romania.
Narcisa Laura MarangociPetru Poni Institute of Macromolecular Chemistry, 41A Aleea Gr. Ghica Vodă, 700487 Iaşi, Romania.ORCID 0000-0002-6629-6460
Codruţa ŞoicaDepartment of Pharmacology-Pharmacotherapy, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Victor Babeș University of Medicine and Pharmacy Timișoara · ROInstitutul de Chimie Macromoleculară Petru Poni

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study focuses on the synthesis via combustion of dysprosium-doped cobalt ferrites that were subsequently physicochemically analyzed in terms of morphological and magnetic properties. Three types of doped nanoparticles were prepared containing different Dy substitutions and coated with HPGCD for higher dispersion properties and biocompatibility, and were later submitted to biological tests in order to reveal their potential anticancer utility. Experimental data obtained through FTIR, XRD, SEM and TEM confirmed the inclusion of Dy

Indexed as

Antineoplastic AgentsBreast NeoplasmsMelanomaNanoparticlesFemaleHumansLightMCF-7 CellsAntineoplastic Agentsanticancercell viabilitycobalt ferritescytotoxicitydysprosium-doped magnetic nanoparticlesWestern blot

Identifiers

PMID37958717
PMCPMC10650938
OpenAlexW4388107241

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.